Viewing Study NCT06850051


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
Study NCT ID: NCT06850051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-02-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-03-19
Start Date Type: ACTUAL
Primary Completion Date: 2026-01-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-01-31
Completion Date Type: ESTIMATED
First Submit Date: 2025-02-11
First Submit QC Date: None
Study First Post Date: 2025-02-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-11
Last Update Post Date: 2025-12-18
Last Update Post Date Type: ESTIMATED